Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/29956
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorGRATIVVOL, Ronnyson Susano
dc.contributor.authorCAVALCANTE, Wagner Cid Palmeira
dc.contributor.authorCASTRO, Luiz Henrique Martins
dc.contributor.authorNITRINI, Ricardo
dc.contributor.authorSIMABUKURO, Mateus Mistieri
dc.date.accessioned2019-01-17T13:33:53Z-
dc.date.available2019-01-17T13:33:53Z-
dc.date.issued2018
dc.identifier.citationCURRENT ONCOLOGY REPORTS, v.20, n.11, article ID 92, 11p, 2018
dc.identifier.issn1523-3790
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/29956-
dc.description.abstractThe disorders of the central nervous system associated with cancer by remote immune-mediated mechanisms are a heterogeneous group. These disorders encompass the classic paraneoplastic disorders and the recently recognized autoimmune encephalitis associated with antibodies against neuronal cell surface or synaptic proteins that occur with or without cancer association. In the last decade, the new surge of interest in neuronal diseases associated with anti-neuronal antibodies led to the rapid discovery of new forms of disease that have different manifestations and were not previously suspected to be immune mediated. The recognition of these syndromes is important because it may lead to early detection of an underlying malignancy and prompt initiation of treatment, improving chances for a better outcome.eng
dc.description.sponsorshipFAPESP
dc.description.sponsorshipNovartis
dc.language.isoeng
dc.publisherSPRINGEReng
dc.relation.ispartofCurrent Oncology Reports
dc.rightsrestrictedAccesseng
dc.subjectLimbic encephalitiseng
dc.subjectOnconeuronal antibodieseng
dc.subjectParaneoplastic neurological syndromeseng
dc.subjectParaneoplastic encephalomyelitiseng
dc.subjectParaneoplastic cerebellar degenerationeng
dc.subjectAutoimmune encephalitiseng
dc.subjectStiff person syndromeeng
dc.subjectProgressive encephalomyelitis with rigidity and myoclonuseng
dc.subjectOpsoclonus-myoclonus syndromeeng
dc.subjectMorvan syndromeeng
dc.subjectOphelia syndromeeng
dc.subjectN-methyl-d-aspartate receptor (NMDAR) encephalitiseng
dc.subjectAnti-AMPA receptor (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) encephalitiseng
dc.subjectAnti-GABAbR (gamma-aminobutyric acid receptor-B) encephalitiseng
dc.subjectAnti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitiseng
dc.subjectAnti-Caspr2 encephalitis (contactin-associated protein-like 2)eng
dc.subjectAnti-glycine receptor (GlyR) antibodieseng
dc.subjectAnti-mGluR5 (metabotropic glutamate receptor 5)eng
dc.subjectAnti-mGLUR1 (metabotropic glutamate receptor 1)eng
dc.subjectAnti-Hu antibodieseng
dc.subjectAnti-Ma2 antibodieseng
dc.subjectAnti-DNER (Deltaeng
dc.subjectNotch-like epidermal growth factor-related receptor) antibodieseng
dc.subjectAnti-CV2/CRMP5 antibodieseng
dc.subject.othernmda receptor encephalitiseng
dc.subject.otherencephalomyelitis sensory neuronopathyeng
dc.subject.othercalcium-channel antibodieseng
dc.subject.othereaton myasthenic syndromeeng
dc.subject.otherstiff-person syndromeeng
dc.subject.othercell lung-cancereng
dc.subject.otherefns task-forceeng
dc.subject.othercerebellar degenerationeng
dc.subject.otherlimbic encephalitiseng
dc.subject.otherglutamate-receptoreng
dc.titleUpdates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromeseng
dc.typearticleeng
dc.rights.holderCopyright SPRINGEReng
dc.identifier.doi10.1007/s11912-018-0721-y
dc.identifier.pmid30415318
dc.subject.wosOncologyeng
dc.type.categoryrevieweng
dc.type.versionpublishedVersioneng
hcfmusp.description.articlenumber92
hcfmusp.description.issue11
hcfmusp.description.volume20
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000449883900003
hcfmusp.origem.id2-s2.0-85056347900
hcfmusp.publisher.cityNEW YORKeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceArino H, 2016, NEUROLOGY, V87, P759, DOI 10.1212/WNL.0000000000003009eng
hcfmusp.relation.referenceArmangue T, 2016, JAMA NEUROL, V73, P417, DOI 10.1001/jamaneurol.2015.4607eng
hcfmusp.relation.referenceBataller L, 2001, BRAIN, V124, P437, DOI 10.1093/brain/124.2.437eng
hcfmusp.relation.referenceBrain WR, 1965, REMOTE EFFECTS CANCeng
hcfmusp.relation.referenceCarvajal-Gonzalez A, 2014, BRAINeng
hcfmusp.relation.referenceCAVINESS JN, 1995, MOVEMENT DISORD, V10, P22, DOI 10.1002/mds.870100106eng
hcfmusp.relation.referenceCORSELLIS JA, 1968, BRAIN, V91, P481, DOI 10.1093/brain/91.3.481eng
hcfmusp.relation.referenceDalakas MC, 2009, CURR TREAT OPTION N, V11, P102, DOI 10.1007/s11940-009-0013-9eng
hcfmusp.relation.referenceDale RC, 2009, ANN NEUROL, V66, P704, DOI 10.1002/ana.21807eng
hcfmusp.relation.referenceDALMAU J, 1991, NEUROLOGY, V41, P1757, DOI 10.1212/WNL.41.11.1757eng
hcfmusp.relation.referenceDalmau J, 2004, BRAIN, V127, P1831, DOI 10.1093/brain/awh203eng
hcfmusp.relation.referenceDALMAU J, 1992, MEDICINE, V71, P59, DOI 10.1097/00005792-199203000-00001eng
hcfmusp.relation.referenceDalmau J, 2012, BRAIN, V135, P1650, DOI [10.1093/brain/aws064, DOI 10.1093/BRAIN/AWS064]eng
hcfmusp.relation.referenceDalmau J, 2007, ANN NEUROL, V61, P25, DOI 10.1002/ana.21050eng
hcfmusp.relation.referenceDalmau J, 2018, NEW ENGL J MED, V378, P840, DOI 10.1056/NEJMra1708712eng
hcfmusp.relation.referenceDalmau J, 2011, LANCET NEUROL, V10, P63, DOI 10.1016/S1474-4422(10)70253-2eng
hcfmusp.relation.referenceDarnell RB, 2003, NEW ENGL J MED, V349, P1543, DOI 10.1056/NEJMra023009eng
hcfmusp.relation.referencede Graaff E, 2012, ANN NEUROL, V71, P815, DOI 10.1002/ana.23550eng
hcfmusp.relation.referenceGable MS, 2012, CLIN INFECT DIS, V54, P899, DOI 10.1093/cid/cir1038eng
hcfmusp.relation.referenceGiometto B, 2010, ARCH NEUROL-CHICAGO, V67, P330, DOI 10.1001/archneurol.2009.341eng
hcfmusp.relation.referenceGranerod J, 2013, EMERG INFECT DIS, V19, P1455, DOI 10.3201/eid1909.130064eng
hcfmusp.relation.referenceGranerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-Xeng
hcfmusp.relation.referenceGraus F, 2004, J NEUROL NEUROSUR PS, V75, P1135, DOI 10.1136/jnnp.2003.034447eng
hcfmusp.relation.referenceGraus F, 2001, BRAIN, V124, P1138, DOI 10.1093/brain/124.6.1138eng
hcfmusp.relation.referenceGraus F, 2002, NEUROLOGY, V59, P764, DOI 10.1212/WNL.59.5.764eng
hcfmusp.relation.referenceGraus F, 2016, LANCET NEUROL, V15, P391, DOI 10.1016/S1474-4422(15)00401-9eng
hcfmusp.relation.referenceGraus F, 2014, BLOOD, V123, P3230, DOI 10.1182/blood-2014-03-537506eng
hcfmusp.relation.referenceGresa-Arribas N, 2014, LANCET NEUROL, V13, P167, DOI 10.1016/S1474-4422(13)70282-5eng
hcfmusp.relation.referenceGultekin SH, 2000, BRAIN, V123, P1481, DOI 10.1093/brain/123.7.1481eng
hcfmusp.relation.referenceHoftberger R, 2015, NEUROLOGY, V84, P2403, DOI 10.1212/WNL.0000000000001682eng
hcfmusp.relation.referenceHoftberger R, 2013, NEUROLOGY, V81, P1500, DOI 10.1212/WNL.0b013e3182a9585feng
hcfmusp.relation.referenceHonnorat J, 2009, J NEUROL NEUROSUR PS, V80, P412, DOI 10.1136/jnnp.2007.138016eng
hcfmusp.relation.referenceHonnorat J, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-22eng
hcfmusp.relation.referenceIorio R, 2013, J NEUROIMMUNOL, V263, P155, DOI 10.1016/j.jneuroim.2013.07.015eng
hcfmusp.relation.referenceIrani SR, 2010, BRAIN, V133, P2734, DOI 10.1093/brain/awq213eng
hcfmusp.relation.referenceKINSBOURNE M, 1962, J NEUROL NEUROSUR PS, V25, P271, DOI 10.1136/jnnp.25.3.271eng
hcfmusp.relation.referenceKlaas JP, 2012, ARCH NEUROL-CHICAGO, V69, P1598, DOI 10.1001/archneurol.2012.1173eng
hcfmusp.relation.referenceLai MZ, 2010, LANCET NEUROL, V9, P776, DOI 10.1016/S1474-4422(10)70137-Xeng
hcfmusp.relation.referenceLai MZ, 2009, ANN NEUROL, V65, P424, DOI 10.1002/ana.21589eng
hcfmusp.relation.referenceLancaster E, 2011, NEUROLOGY, V77, P1698, DOI 10.1212/WNL.0b013e3182364a44eng
hcfmusp.relation.referenceLancaster Eric, 2015, Continuum (Minneap Minn), V21, P452, DOI 10.1212/01.CON.0000464180.89580.88eng
hcfmusp.relation.referenceLancaster E, 2012, NAT REV NEUROL, V8, P380, DOI 10.1038/nrneurol.2012.99eng
hcfmusp.relation.referenceLancaster E, 2011, ANN NEUROL, V69, P303, DOI 10.1002/ana.22297eng
hcfmusp.relation.referenceLancaster E, 2010, LANCET NEUROL, V9, P67, DOI 10.1016/S1474-4422(09)70324-2eng
hcfmusp.relation.referenceLeypoldt F, 2015, ANN NY ACAD SCI, V1338, P94, DOI 10.1111/nyas.12553eng
hcfmusp.relation.referenceLopez-Chiriboga AS, 2016, NEUROLOGY, V86, P1009, DOI 10.1212/WNL.0000000000002476eng
hcfmusp.relation.referenceMarignier R, 2010, ARCH NEUROL-CHICAGO, V67, P627, DOI 10.1001/archneurol.2010.51eng
hcfmusp.relation.referenceMason WP, 1997, BRAIN, V120, P1279, DOI 10.1093/brain/120.8.1279eng
hcfmusp.relation.referenceMathew RM, 2007, NEUROLOGY, V68, P900, DOI 10.1212/01.wnl.0000252379.81933.80eng
hcfmusp.relation.referenceMurinson BB, 2008, NEUROLOGY, V71, P1955, DOI 10.1212/01.wnl.0000327342.58936.e0eng
hcfmusp.relation.referencePellkofer H, 2004, BRAIN, V127, P1822, DOI 10.1093/brain/awh205eng
hcfmusp.relation.referencePetit-Pedrol M, 2014, LANCET NEUROL, V13, P276, DOI 10.1016/S1474-4422(13)70299-0eng
hcfmusp.relation.referenceRosenfeld Myrna R, 2012, Neurol Clin Pract, V2, P215eng
hcfmusp.relation.referenceRosenfeld Myrna R, 2012, Continuum (Minneap Minn), V18, P366, DOI 10.1212/01.CON.0000413664.42798.aaeng
hcfmusp.relation.referenceSabater L, 2014, LANCET NEUROL, V13, P575, DOI [10.1016/S1474-4421(14)70051-1, 10.1016/S1474-4422(14)70051-1]eng
hcfmusp.relation.referenceSabater L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060438eng
hcfmusp.relation.referenceSahu Jitendra Kumar, 2011, Pract Neurol, V11, P160, DOI 10.1136/practneurol-2011-000017eng
hcfmusp.relation.referenceSaiz A, 2009, J NEUROL NEUROSUR PS, V80, P404, DOI 10.1136/jnnp.2008.158246eng
hcfmusp.relation.referenceSaiz A, 2008, BRAIN, V131, P2553, DOI 10.1093/brain/awn183eng
hcfmusp.relation.referenceSchmitt SE, 2012, NEUROLOGY, V79, P1094, DOI 10.1212/WNL.0b013e3182698cd8eng
hcfmusp.relation.referenceSimabukuro MM, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000073eng
hcfmusp.relation.referenceSmitt PS, 1996, J NEUROIMMUNOL, V71, P199, DOI 10.1016/S0165-5728(96)00153-1eng
hcfmusp.relation.referenceSmitt PS, 2000, NEW ENGL J MED, V342, P21, DOI 10.1056/NEJM200001063420104eng
hcfmusp.relation.referenceTitulaer MJ, 2011, EUR J NEUROL, V18, P19, DOI 10.1111/j.1468-1331.2010.03220.xeng
hcfmusp.relation.referenceTitulaer MJ, 2013, LANCET NEUROL, V12, P157, DOI 10.1016/S1474-4422(12)70310-1eng
hcfmusp.relation.referenceTROTTER JL, 1976, ARCH NEUROL-CHICAGO, V33, P660, DOI 10.1001/archneur.1976.00500090066014eng
hcfmusp.relation.referencevan Sonderen A, 2016, NEUROLOGY, V87, P1449eng
hcfmusp.relation.referencevan Sonderen A, 2016, NEUROLOGY, V87, P521, DOI 10.1212/WNL.0000000000002917eng
hcfmusp.relation.referenceVedeler CA, 2006, EUR J NEUROL, V13, P682, DOI 10.1111/j.1468-2006.01266.xeng
hcfmusp.relation.referenceVitaliani R, 2005, ANN NEUROL, V58, P594, DOI 10.1002/ana.20614eng
hcfmusp.relation.referenceVoltz R, 1998, NEUROLOGY, V51, P1146, DOI 10.1212/WNL.51.4.1146eng
hcfmusp.relation.referenceVora NM, 2014, NEUROLOGY, V82, P443, DOI 10.1212/WNL.0000000000000086eng
hcfmusp.relation.referenceWHITELEY AM, 1976, BRAIN, V99, P27, DOI 10.1093/brain/99.1.27eng
hcfmusp.relation.referenceWILKINSO.PC, 1965, BRAIN, V88, P529, DOI 10.1093/brain/88.3.529eng
hcfmusp.relation.referenceWirtz PW, 2005, J NEUROIMMUNOL, V164, P161, DOI 10.1016/j.jneuroim.2005.04.001eng
dc.description.indexMEDLINEeng
dc.identifier.eissn1534-6269
hcfmusp.citation.scopus59-
hcfmusp.scopus.lastupdate2024-04-12-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MNE
Departamento de Neurologia - FM/MNE

Artigos e Materiais de Revistas Científicas - HC/ICESP
Instituto do Câncer do Estado de São Paulo - HC/ICESP

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/15
LIM/15 - Laboratório de Investigação em Neurologia

Artigos e Materiais de Revistas Científicas - LIM/45
LIM/45 - Laboratório de Fisiopatologia Neurocirúrgica

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_GRATIVVOL_Updates_in_the_Diagnosis_and_Treatment_of_Paraneoplastic_2018.PDF
  Restricted Access
publishedVersion (English)469.99 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.